chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Within one hour of receiving his second injection of Gardasil, my son began to behave as if he was drunk, he was confused, he was nauseated and lost his appetite. The symptoms eased a bit within an hour, but the nausea lasted for approximately 3 hours, and afterward he was tired for the remainder of the day.  It took several hours for his appetite to return.  Most frightening:  he cannot clearly remember what happened.
no adverse event; Inbound call from physician calling to report TE for GARDASIL-9.  Caller reports that vaccine was administered to patient following excursion.  Confirmed no symptoms or other adverse events were reported.  No other information at this time.  Permissi; This spontaneous report was received from a physician, referring to a patient of unknown age and gender.  The patient's concomitant medication, pertinent medical history and drug reactions/allergies were not reported.  On 10-OCT-2023, the patient was vaccinated with improperly stored vaccine of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) injection, 0.5 milliliter/once, product quantity: 1, lot #W014513, expiration date: 26-JAN-2025 (strength, and route of administration were not provided) administered for prophylaxis (Product storage error). The vaccine was exposed to 0 degree Celsius (C) for 15 minutes and the data logger was involved on an unspecified date. There was no previous temperature excursion. It was confirmed no symptoms or other adverse events were reported.
This spontaneous report as received from a pharmacist via company representative refers to a female patient of unknown age. On an unknown date the patient was vaccinated with a dose of PNEUMOVAX 23 (dose, route of administration, LOT# and expiration date were not reported). Other suspect therapy included a dose of influenza virus vaccine (manufacturer unknown) (dose, route of administration, LOT# and expiration date were not reported), administered on an unspecified date. The patient was found unconscious (date unspecified) and rushed to emergency room (on an unspecified date, after receiving PNEUMOVAX 23). The patient was admitted in an unspecified hospital (on an unknown date) for an unspecified length of time. The outcome of the event was not reported. The relatedness among the event and PNEUMOVAX 23 and influenza virus vaccine (manufacturer unknown) was not reported. Upon internal review the event "patient was found unconscious" was considered to be medically significant. Additional information has been requested.
pt recvd vax;1 wk p/ dose 1 exp optical disturbance;sxs of mult sclerosis;exp numbness;3-4 wks p/ dose 2, dx w/ mult sclerosis;adm to hosp;has difficulty walking & has approx 3 to 5 lesions at this point in time;
Patient received Varicella vaccine 3/22/07 in left posterior upper arm. Patient presented 2 days later with severe redness, swelling, pain left posterior upper arm. Getting worse with time. Diagnosed with Atanax and covered with antibiotic for possible cellulitis.
This spontaneous report as received from a physician refers to a 22 years old female patient with no medical history and no drug allergy. The patient was vaccinated with PNEUMOVAX23 (lot# unspecified) and an unspecified flu vaccine (manufacturer unknown) on 14-OCT-2012 at a local Pharmacy by an unspecified healthcare provider and experienced pain at the injection site of the PNEUMOVAX23 later that evening on 14-OCT-2012. No other co-suspects were reported. On approximately 16-OCT-2012, the patient also developed a fever and chills 48 hours after receiving PNEUMOVAX23 and the unspecified flu vaccine (manufacturer unknown). Unspecified pain medication was given as treatment. The outcome of pain at the injection site, chills and fever was reported as not recovered. The patient had sought unspecified medical attention. No lab tests were performed. Additional information is not expected.
Area around injection became red, swollen over 48h after vaccine. Clinically appears like cellulitis.
Breakthrough case admission after 2 vaccines Moderna 1/28/21 Lot# 028L20A;  Moderna 2/25/21 Lot# 004M20A
This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. There was no medical history, concurrent conditions reported. On 06-AUG-2010 the patient was vaccinated with GARDASIL first dose and on 30-DEC-2013 the patient was vaccinated with GARDASIL dose 2 reported as 120 y, strength, lot# route not reported) and no adverse symptoms reported. Additional information has been requested.
After receiving vaccine, patient stood up to leave when she suddenly felt flushed and nauseous. She vomited x1. BP checked (100/60). Had patient lay down for 20 min. Patient felt better. Checked BP again (102/64). Released to go home.
Mild Shingles symptoms, left side of face/neck. Oral sores on left lower gums. Treated with anti-viral meds.
Breakthrough COVID infection in fully vaccinated patient. Positive date 09/07/2021.
Quarter sized spot of Alopecia Areata on Childs upper right lobe of head; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP).  A 9 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 06Dec2021 16:15 (Lot number: FK5618) at the age of 9 years as dose 2, single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. Vaccination history included: Bnt162b2 (Dose Number: 1, Batch/Lot No: FK5618, Location of injection: Arm Left, Vaccine Administration Time: 04:15 PM), administration date: 15Nov2021, when the patient was 9 years old, for COVID-19 Immunization. The following information was reported: ALOPECIA AREATA (non-serious), outcome "not recovered", described as "Quarter sized spot of Alopecia Areata on Childs upper right lobe of head". The event "quarter sized spot of alopecia areata on childs upper right lobe of head" was evaluated at the physician office visit. It was unknown if therapeutic measures were taken as a result of alopecia areata.  Additional information: The patient did not have any allergies. The patient had no other vaccine within four weeks and no other medications received within 2 weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Device time stamp was 07Dec2021.  No follow-up attempts are possible. No further information is expected.
Thursday Oct 11 2018 had tetanus vaccine and flu shot ..Friday morning had headache Saturday didn't feel good ..felt tired and Head was worse ..Sunday now my arms hurting..Monday Arm bruised where I had tetanus, upper muscle swollen, headache, tired, all my joints in both arms and legs feel like they are a cold burning ache..hurts to drive. Tuesday morning called doctor..Wednesday talked to drs was told I was having allergic reaction to take BENADRYL at night and MOTRIN daytime for few days to help inflammation ..call in few days if doesn't change.
Subsequent to receiving varicella virus vaccine live the pts sitter developed a varicella rash in face, arms, and legs.
Systemic: Allergic: Swelling of Face / Eyes / Mouth / Tongue-Mild, Systemic: Nausea-Medium, Systemic: Vomiting-Medium
Patient came with her mother to get the meningococcal vaccine. After the vaccine mother was waiting for immunization documentation while the patient left the immunization area and was seated in the stores health self-screening machine next to her mother.  Patient fainted and she was immediately laid flat on her back at which point she recovered and stood up. Code white was called, but not 911. They where asked to remained in the pharmacy area for approx 20 minutes seated which they complied. When they were ready to leave the store manager brought over a wheelchair and she was wheeled to their vehicle.
AFLURIA vaccine given on L deltoid, within next 3 hours an indurated area formed approximately 3" in diameter.  Redness then developed on entire deltoid area extending into the axilla and onto L anterior chest wall.  Area warm to touch.  By 10/28/2008 pm- redness receding, warmth remains, decreased induration @ injection site small amt soreness.
Client stated right arm began swelling with redness and tenderness approximately one hour after receiving Tdap. R deltoid sore to touch and warm for about a week. Swelling subsided after that time period. No further follow up recommended. Was accessed by Medical Director. Warm to cold compresses recommended.
Patient described feeling cold to the touch on her arm from the shoulder to the elbow on the arm receiving the vaccination ever since getting the Fluzone-HD vaccine last year and has continued even today and feels the same after being vaccinated this year.
Patient given an adult dose of Pfizer when patient is a pediatric patient. Infectious disease doctors on site consulted, parents of patient notified of  error and recommendations form infectious disease specialists.
How long is it normal for the lump in the armpit to be swollen; How long is it normal for the lump in the armpit to be swollen; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 14-Jun-2021 and was forwarded to Moderna on 14-Jun-2021.    This spontaneous case was reported by a consumer and describes the occurrence of SKIN MASS (How long is it normal for the lump in the armpit to be swollen) and SWELLING (How long is it normal for the lump in the armpit to be swollen) in a 61-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced SKIN MASS (How long is it normal for the lump in the armpit to be swollen) and SWELLING (How long is it normal for the lump in the armpit to be swollen). At the time of the report, SKIN MASS (How long is it normal for the lump in the armpit to be swollen) and SWELLING (How long is it normal for the lump in the armpit to be swollen) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.     Concomitant product use was not provided by the reporter.  Treatment information was not provided.
Heart was beating 150 per minute; Heart not feeling right; This is a spontaneous report from a contactable consumer (patient herself). A 34-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: EW0164), via an unspecified route of administration in left arm on 20Apr2021 at 11:30 (at the age of 34-year-old) as a single dose for COVID-19 immunisation. The patient's medical history included hypertension, diabetes. Concomitant medications included ongoing beclometasone dipropionate (BELAR) orally at 3 mg, once a day, ongoing alprazolam (XANAX), orally at 0.2 mg, once a day, ongoing clonidine orally at 0.2 mg, thrice a day for hypertension, ongoing amlodipine orally at 10 mg, once a day for hypertension, ongoing lisinopril orally at 40 mg, once a day for hypertension, insulin lispro (HUMALOG) at 24 united states pharmacopeia unit, thrice a day (924 units, 3 times a day, injection) for diabetes, metformin orally at 24 united states pharmacopeia unit, thrice a day (924 units, 3 times a day, injection) for diabetes. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: ET7533), via an unspecified route of administration on 30Mar2021 at 11:30 (at the age of 34-year-old) as a single dose for COVID-19 immunisation. Patient stated, "she was calling to see if you report adverse reactions." When probed for the concern, patient stated, "she took her second dose of Pfizer Vaccine on 20Apr2021 and on 23Apr2021) she had to call Ambulance because her heart was beating 150 per minute and they said it was because of Covid Vaccine. They told her that it was "fighting off" (not clarified) the vaccine and told her to wait three weeks to see what would happen, so it was over a month now and her heart was still not feeling right. It was still beating over 100 per minute. Patient have to go to the Cardiologist doctor tomorrow, and they are going to check her heart." Patient added, "ambulance came to home to check her vitals." Patient stated that she did not receive treatment medication for the problem, but she was on the blood pressure medication because nurse told her to take one of blood pressure medication if that would make her heart go down and they went down a little bit. No other vaccines were taken prior to vaccination. Patient was calling because she had side effects with Pfizer Vaccine, she took her second dose 20Apr2021 and the next day (21Apr2021) she had to end up calling the ambulance because her heart was beating 150 beats per minute and she have been testing and they said it was because that was side effect of vaccine and go to doctor 3 weeks later if it's still like that so not it's 31May2021 and her heart still beating fast, and it was supposed to reduce over a month." No investigation assessment. The patient underwent lab tests and procedures which included heart beat: 150 per minute on 21Apr2021 and heart beat: Over 100 per minute on an unspecified date in 2021. The outcome of the events was not recovered.
Approximately five minutes of receiving the second vaccine broke out in hives everywhere started experiencing throat tingling. Was taken to ER. I am a nurse  at hospital Was given Solu-Medrol and Benadryl IV in ER
Information has been received from a registered nurse from the infectious control department concerning a 57 year old male with hypertension and arthritis and a history of a coronary artery bypass, cardiac catheterization, and renal failure that required dialysis caused by a "combination of Toradol and contrast dye, who on 15-NOV-2006, in a physician's office was vaccinated subcutaneously with a dose of Pneumovax 23 (lot #651437/0899F). On 16-NOV-2006 the patient developed a localized reaction and was started on Keflex. On 18-NOV-2006 the patient was hospitalized with cellulitis. The area affected was initially approximately 3 inches in diameter and then the entire upper arm and several inches below the elbow became involved. The patient was treated with vancomycin 15 gm every 12 hours and rifampin 300 mg BID. A chest x-ray and arm x-rays were performed. A white blood cell count was 15, 000. On 20-NOV-2006 he was discharged home and was reported to be recovering. No product quality complaint was involved. The reporter considered that cellulitis was an other important medical event because the patient required antibiotics. Additional information has been requested.
Case number PHEH2015US025825, is a spontaneous report initially received from a health care professional on 07 Dec 2015. This report refers to a 46 years old male patient. Medical history and concomitant medications were not reported. The patient tolerated vaccine in past. The patient was vaccinated with FLUVIRIN PFS (batch number: 158301) intramuscularly into left deltoid at a dose of 0.5 ml (prefilled) on 06 Dec 2015. It was reported FLUVIRIN was administered to patient after 5 hours of power outage of refrigerator and possible temperature excursion. No recorded temperatures were reported. No adverse event was reported. Follow up received from a health care professional on 29 Jan 2016: Updated Vaccine application site and dose and narrative updated accordingly.
Pt c/o of pain, swelling, increased warmth, induration at inject site, temp 104, felt like she had the flu w/ aches & soreness in joints.
pt recvd vax 5APR92 & w/in 4 to 5 minutes following the inject pt collapsed, turned blue, foamed @ mouth, eyes rolled back into head, became incontinent of bladder, sz activity, h/a, stomachache, vomiting;
Severe swelling and joint pain in left ankle/foot starting upon first physical activity post shot.  Continued pain and swelling since.  Pain in feet very similar to symptoms experienced back in 1992 when I had Lyme's disease.
Complained of arm pain, redness, swelling approximately 12h after vaccine, not itchy, no fevers, worsened during the day. Evaluated by MD at approximately 48 hours and very erythematous (L) Proximal arm, 16cm x 14cm erythematous region, increased warmth, improved by next day.
discharged.Patient is 68-year-old female who has a past medical history of type 2 diabetes mellitus, emphysema, hypertension.  She presented to the hospital with respiratory symptoms of increased congestion and weakness as well as increasing shortness of breath.  Patient was diagnosed with COVID-19 infection.  Patient reports previous vaccination however does not have current booster.  She was admitted to the hospital with acute hypoxic respiratory failure currently requiring about 4-6 L of oxygen.  Her chest x-rays did not reveal any evidence of pneumonic process or infiltrate.  She was admitted and started on steroid treatment as well as remdesivir.  Patient did well with supportive care COVID-19 treatment.  And her oxygen requirement was weaned down.  She was evaluated by Pulmonary rehab prior to discharge in set up with home oxygen.  She was not having any further complaints of difficulty breathing and she was stable for discharge home and to continue with oral dexamethasone course along with albuterol inhaler.
MILD INFLAMMATION AND REDNESS IN SHOULDER AND ARM. SOME BRUISING REMAINS.  PATIENT CLAIMS SHE GOT AN UPPER RESPIRATORY INFECTION, ALTHOUGH RELATIONSHIP TO VACCINE IS UNLIKELY.
Nauseous; Dizzy; This is a spontaneous report from a contactable consumer (patient). A 57-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19  VACCINE, Solution for injection; lot number and expiration date: not reported), via an unspecified route of administration, on 17Jun2021 (at the age of 57-year-old), as DOSE 2, SINGLE for covid-19 immunization. The patient's medical and concomitant medications were not reported. Historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), DOSE 1, SINGLE for covid-19 immunization (no reaction experienced). The patient had his second shot of the Pfizer COVID 19 vaccine yesterday and is nauseous and dizzy. It was further reported as: patient got the vaccine on 17Jun2021 and symptoms like dizziness started at 4:00pm and onwards; and on 18Jun2021, he has a little bit of dizziness as well as nauseous. Patient also reported that, symptoms are very minor and very slight. The outcome of events was not recovered at the time of the report.  Information on lot/batch number has been requested.
vision distortion while driving reports seeing bright lights and unable to keep eyes open States he pulled over was having nausea/vomiting, lightheaded, confusion, changes in speech. symptoms resolved recommended he follow up with pcp to report issues and potentially order at CT-head. Informed him if symptoms return to call 911 immediately and get checked out for potential stroke like symptoms. informed him or symptoms such as; CP, paralysis, numbness, tingling, confusion, slurred speech, droop of the face, drooling that may occur and if any begin to seek emergency treatment right away. Informed him with his pre-existing medical conditions and medications like testosterone he is at a higher risk of heart attack and strokes, caller verbalized understanding.  4/11-RN spoke with patient regarding seeing bright lights and unable to keep eyes open States he pulled over was having nausea/vomiting, lightheaded, confusion, changes in speech. He states that symptoms resolved
Initial report received from nurse on 13 Jan 2010: A child patient under the age of 4 years was vaccinated with influenza virus vaccine (manufacturer unknown) on 13 Jan 2010. No adverse event was reported.
sore arm; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 72 year-old female patient received bnt162b2 (BNT162B2), administered in arm right, administration date 03Mar2021 10:00 (Lot number: EN6200) as dose 2, single for covid-19 immunisation. Relevant medical history included: "HPB" (unspecified if ongoing), notes: Hepato-Pancreato-Biliar  (all treated); "Supraventricular tachycardia" (unspecified if ongoing); "Hypothyroidism" (unspecified if ongoing). Concomitant medication(s) included: FLECAINIDE ACETATE; LISINOPRIL; SYNTHROID. Past drug history included: Anesthesia, reaction(s): "Allergy", notes: no, other than nausea reactions to anesthesia. Vaccination history included: Bnt162b2 (Dose Number: 1, Batch/Lot No: EL9265, Arm Left, 10:00 AM), administration date: 10Feb2021, for Covid-19 immunisation, reaction(s): "Fatigue"; Bnt162b2 (Dose Number: 1, Batch/Lot No: EL9265, Arm Left, 10:00 AM), administration date: 10Feb2021, for COVID-19 immunisation, reaction(s): "sore in arm". The following information was reported: PAIN IN EXTREMITY (non-serious) with onset 2021, outcome "unknown", described as "sore arm". Therapeutic measures were not taken as a result of pain in extremity.  Additional information included: The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19.  No follow-up attempts are possible. No further information is expected.
Information has been received from a lawyer regarding a case in litigation concerning a female of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. The patient was prescribed the ZOSTAVAX by a healthcare provider for the long-term prevention of shingles and zoster-related conditions. In January 2017 the patient was administered the ZOSTAVAX by a health care provider (lot number, dosage and route of administration not provided). On an unknown date, the patient was treated by a health care provider for the following injury resulting from her use of ZOSTAVAX: shingles. The patient claims damages as a result of: injury to herself, loss of consortium, and economic losses. The outcome of the shingles is unknown. Additional information has been requested.
Patient presenting to the ED with a feeling of generalized achiness with right arm soreness, which began 1 days ago.  Patient received a COVID vaccine in the right arm 2 days ago and a day later started feeling achiness and right arm soreness.  He is actually better today.  He had some chest pain transiently last night but that resolved.  He has no shortness of breath or fever but felt warm per his mother. patient was given Acetominophen top treat his symptoms, and was discharged home by the physician.
11/24: Arm was tender. 11/25/-11/27: From the shoulder to elbow the arm was burning hot and swollen. Patient also was lethargic and developed chills and cold/flu symptoms. 11/29: Bruising in the form of a "band" around the site of vaccination; arm felt cold.
pt. developed Pulmonary Emboli with symptoms starting about 2 weeks after 2nd vaccine.  He ultimately required hospitalization.
A few hours after vaccination - pale, fatigued - eyes were twitching - 12-16 hours later - dizzy - pale and eyes were twitching again.